{"title":"更正 \"沙利度胺治疗重型β地中海贫血患儿的长期疗效和安全性\"。","authors":"","doi":"10.1002/pbc.31411","DOIUrl":null,"url":null,"abstract":"<p>Jian X, Liu X, Peng W, Li L, Hua F, Chen K, Zhang J, Luo S, Yang K, Wu Y. Long-term efficacy and safety of thalidomide treatment in children with β-thalassemia major. Pediatr Blood Cancer. 2023 Apr 28:e30391. https://doi.org/10.1002/pbc.30391.</p><p>The affiliation “Department of Hematology, West China Hospital, Chengdu, China” should be corrected to “Department of Hematology, West China Hospital, Sichuan University, Chengdu, China.”</p><p>Due to an oversight, the affiliation is incomplete for author Yu Wu.</p><p>The author byline and correspondence sections should read:</p><p>Jian Xiao<sup>1,2</sup>, Xiaodong Liu<sup>2</sup>, Wei Peng<sup>2</sup>, Lan Li<sup>2</sup>, Fang Hua<sup>2</sup>, Kun Chen<sup>2</sup>, Jin Zhang<sup>2</sup>, Shan Luo<sup>2</sup>, Kun Yang<sup>2*</sup>, Yu Wu<sup>1*</sup></p><p><sup>1</sup>Department of Hematology, West China Hospital, Sichuan University, Chengdu, China;</p><p><sup>2</sup>Department of Hematology, Zigong First People's Hospital, Zigong, China</p><p><sup>*</sup> Correspondence to:</p><p>Kun Yang, Department of Hematology, Zigong First People's Hospital, Zigong, 643000, China; E-mail: [email protected]</p><p>Yu Wu, Department of Hematology, West China Hospital, Sichuan University, Chengdu, 610041, China, E-mail: [email protected]</p><p>We apologize for this error.</p>","PeriodicalId":19822,"journal":{"name":"Pediatric Blood & Cancer","volume":"72 1","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2024-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/pbc.31411","citationCount":"0","resultStr":"{\"title\":\"Correction to “Long-term efficacy and safety of thalidomide treatment in children with β-thalassemia major”\",\"authors\":\"\",\"doi\":\"10.1002/pbc.31411\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Jian X, Liu X, Peng W, Li L, Hua F, Chen K, Zhang J, Luo S, Yang K, Wu Y. Long-term efficacy and safety of thalidomide treatment in children with β-thalassemia major. Pediatr Blood Cancer. 2023 Apr 28:e30391. https://doi.org/10.1002/pbc.30391.</p><p>The affiliation “Department of Hematology, West China Hospital, Chengdu, China” should be corrected to “Department of Hematology, West China Hospital, Sichuan University, Chengdu, China.”</p><p>Due to an oversight, the affiliation is incomplete for author Yu Wu.</p><p>The author byline and correspondence sections should read:</p><p>Jian Xiao<sup>1,2</sup>, Xiaodong Liu<sup>2</sup>, Wei Peng<sup>2</sup>, Lan Li<sup>2</sup>, Fang Hua<sup>2</sup>, Kun Chen<sup>2</sup>, Jin Zhang<sup>2</sup>, Shan Luo<sup>2</sup>, Kun Yang<sup>2*</sup>, Yu Wu<sup>1*</sup></p><p><sup>1</sup>Department of Hematology, West China Hospital, Sichuan University, Chengdu, China;</p><p><sup>2</sup>Department of Hematology, Zigong First People's Hospital, Zigong, China</p><p><sup>*</sup> Correspondence to:</p><p>Kun Yang, Department of Hematology, Zigong First People's Hospital, Zigong, 643000, China; E-mail: [email protected]</p><p>Yu Wu, Department of Hematology, West China Hospital, Sichuan University, Chengdu, 610041, China, E-mail: [email protected]</p><p>We apologize for this error.</p>\",\"PeriodicalId\":19822,\"journal\":{\"name\":\"Pediatric Blood & Cancer\",\"volume\":\"72 1\",\"pages\":\"\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2024-11-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/pbc.31411\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pediatric Blood & Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/pbc.31411\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric Blood & Cancer","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/pbc.31411","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
Correction to “Long-term efficacy and safety of thalidomide treatment in children with β-thalassemia major”
Jian X, Liu X, Peng W, Li L, Hua F, Chen K, Zhang J, Luo S, Yang K, Wu Y. Long-term efficacy and safety of thalidomide treatment in children with β-thalassemia major. Pediatr Blood Cancer. 2023 Apr 28:e30391. https://doi.org/10.1002/pbc.30391.
The affiliation “Department of Hematology, West China Hospital, Chengdu, China” should be corrected to “Department of Hematology, West China Hospital, Sichuan University, Chengdu, China.”
Due to an oversight, the affiliation is incomplete for author Yu Wu.
The author byline and correspondence sections should read:
Jian Xiao1,2, Xiaodong Liu2, Wei Peng2, Lan Li2, Fang Hua2, Kun Chen2, Jin Zhang2, Shan Luo2, Kun Yang2*, Yu Wu1*
1Department of Hematology, West China Hospital, Sichuan University, Chengdu, China;
2Department of Hematology, Zigong First People's Hospital, Zigong, China
* Correspondence to:
Kun Yang, Department of Hematology, Zigong First People's Hospital, Zigong, 643000, China; E-mail: [email protected]
Yu Wu, Department of Hematology, West China Hospital, Sichuan University, Chengdu, 610041, China, E-mail: [email protected]
期刊介绍:
Pediatric Blood & Cancer publishes the highest quality manuscripts describing basic and clinical investigations of blood disorders and malignant diseases of childhood including diagnosis, treatment, epidemiology, etiology, biology, and molecular and clinical genetics of these diseases as they affect children, adolescents, and young adults. Pediatric Blood & Cancer will also include studies on such treatment options as hematopoietic stem cell transplantation, immunology, and gene therapy.